NYSE:NGVT - Ingevity Stock Price, Forecast & News

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Ingevity Corp (NYSE:NGVT) released its quarterly earnings results on Wednesday, October, 23rd. The company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.04. The firm earned $359.90 million during the quarter, compared to analyst estimates of $365.44 million. Ingevity had a net margin of 14.31% and a return on equity of 53.69%. The company's revenue was up 15.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.16 EPS. View Ingevity's Earnings History.

Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Ingevity.

Ingevity updated its FY 2019 earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.28-1.3 billion, compared to the consensus revenue estimate of $1.33 billion.

8 equities research analysts have issued 12-month target prices for Ingevity's stock. Their forecasts range from $96.00 to $130.00. On average, they anticipate Ingevity's share price to reach $110.38 in the next twelve months. This suggests a possible upside of 33.7% from the stock's current price. View Analyst Price Targets for Ingevity.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.

News stories about NGVT stock have been trending extremely negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ingevity earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Ingevity.

Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), Huntsman (HUN), W. R. Grace & Co (GRA), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Balchem (BCPC), Chemours (CC), Olin (OLN), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Livent (LTHM) and Innophos (IPHS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include AbbVie (ABBV), Pfizer (PFE), Verizon Communications (VZ), Costco Wholesale (COST), NVIDIA (NVDA), General Electric (GE), Quaker Chemical (KWR), Paypal (PYPL), Zebra Technologies (ZBRA) and Boeing (BA).

Ingevity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (0.59%), Patten & Patten Inc. TN (0.40%), Calamos Advisors LLC (0.11%), Gateway Investment Advisers LLC (0.08%), Mitsubishi UFJ Asset Management UK Ltd. (0.04%) and Patten Group Inc. (0.02%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity.

NGVT stock was sold by a variety of institutional investors in the last quarter, including Patten & Patten Inc. TN, Mitsubishi UFJ Asset Management UK Ltd., Nisa Investment Advisors LLC, State of Alaska Department of Revenue and Copper Rock Capital Partners LLC. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity.

NGVT stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, Gateway Investment Advisers LLC, Fruth Investment Management and Patten Group Inc.. View Insider Buying and Selling for Ingevity.

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NGVT stock can currently be purchased for approximately $82.56.

Ingevity has a market capitalization of $3.45 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.View Additional Information About Ingevity.

The official website for Ingevity is http://www.ingevity.com/.

Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]